# Majorbio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/majorbio

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.majorbiogroup.com
- Latest round: Series C (Mar 3, 2016)
- Investors on record: 3

## About

Based in Shanghai, China and established in 2009, Majorbio is a biomedical technology company that provides bioinformatics analysis technology services. In 2012, the company acquired ISO9000 quality management system certification. In March 2016, the firm closed a series C funding. The company has offices in Beijing, Guangzhou, Wuhan and other cities.

The company provides animal and plant genome sequencing, microbial genome sequencing, metagenomic sequencing and other services. Its main products include mass spectrometry platform products and molecular diagnostic products. Molecular diagnostic products include folic acid medication gene detection kits, children's safe medication gene detection kits, and warfarin medication gene detection kits.

The company’s revenue is generated by providing bioinformatics analysis technology services and reagent products.

## Funding rounds

- Series C, Mar 3, 2016 — Tianjin Venture Capital
- Series B, Apr 28, 2015 — V Star Capital
- Series A, Nov 1, 2012 — Sinovo

## Investors

- Sinovo — Series A
- V Star Capital (https://capitalatlas.ai/funds/v-star-capital) — Series B
- Tianjin Venture Capital (https://capitalatlas.ai/funds/tianjin-venture-capital) — Series C